Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation

Perez-Revuelta, B. I.; Hettich, M. M.; Ciociaro, A.; Rotermund, C.; Kahle, P. J.; Krauss, S.; Di Monte, D. A.

dc.contributor.author	Rotermund, Carola
dc.contributor.author	Kahle, Philipp J.
dc.date.accessioned	2014-10-07T14:41:52Z
dc.date.available	2014-10-07T14:41:52Z
dc.date.issued	2014
dc.identifier.issn	2041-4889
dc.identifier.uri	http://hdl.handle.net/10900/56832
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/cddis.2014.175	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140813180100_00556	de_DE
utue.personen.roh	Perez-Revuelta, B. I.
utue.personen.roh	Hettich, M. M.
utue.personen.roh	Ciociaro, A.
utue.personen.roh	Rotermund, C.
utue.personen.roh	Kahle, P. J.
utue.personen.roh	Krauss, S.
utue.personen.roh	Di Monte, D. A.
dcterms.isPartOf.ZSTitelID	Cell Death & Disease	de_DE
dcterms.isPartOf.ZS-Issue	Article e1209	de_DE
dcterms.isPartOf.ZS-Volume	5	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE